An epidemiological working definition will be pragmatic and helpful to assess the magnitude of re-infection in most population and resource constrained settings. Two positive tests at an interval of…
SARSCoV2
-
-
When the researchers created colder conditions, they found that the virus replicated faster than when infections were carried out at 37 degrees Celsius to mimic the lower lung environment. Natural…
-
People having SARS-CoV-2, the virus that causes covid-19, may have protection against future infection for a few months, a research published in the JAMA Internal Medicine showed. The findings could…
- Science
The Hindu Explains | What has the WHO team’s field visit to China thrown up regarding the spread of SARS-CoV-2?
Has the possibility of a lab-leak been ruled out? Did the virus directly jump from bats to humans? The story so far: After several months of ay, concerns over access,…
-
WHO food safety and animal diseases expert Peter Ben Embarek made the assessment in a summation on Tuesday The SARS-CoV-2 virus was unlikely to have leaked from a laboratory in…
-
The tool, designed by ACTREC, Tata Memorial Centre, is handy to analyse SARS-CoV-2 genome information uploaded to the GISAID database An automated computational tool – Infectious Pathogen Detector (IPD) –…
-
On Sunday, millions of people across the country will tune in for Super Bowl LV. Whether or not this … [+] will fuel the Covid-19 pandemic depends on whether people…
- News
US detects first instance of COVID-19 disease from South African SARS-CoV-2 variant – World News , Firstpost
Scientists are primarily concerned with the emergence of three specific variants that are likely to spread easily. A new variant of the coronavirus emerged Thursday in the United States,…
- News
UK SARS-CoV-2 strain more transmissible, possibly deadlier than others, scientists warn- Technology News, Firstpost
Agence France-PresseJan 27, 2021 13:55:59 IST The announcement that the coronavirus strain sweeping Britain could be deadly as well as transmissible has raised fresh concerns about the variant…
-
Hyderabad: The SARS-CoV-2, which causes Covid-19, has shown a mutation, N440K, in 34 per cent of the samples analysed in Andhra Pradesh, Telangana, Maharashtra and Karnataka. The mutation was found…
-
As part of various initiatives towards mitigating COVID-19, CSIR-Central Food Technological Research Institute (CFTRI) signed an MoU with Clevergene, a Bengaluru-based company, for sequencing the SARS-CoV-2 genome. It is expected…
- Science
Coronavirus | N501Y mutation in SARS-CoV-2 virus causes increased infectivity in mice: researchers
The mutation seems to provide a favourable interaction with mouse ACE2 for docking and entry, they say In a preliminary report posted on December 19, Dr. Andrew Rambaut…
- News
Pfizer’s Covid-19 vaccine found effective against UK, SA variants of SARS-CoV-2 virus, study reports – Health News , Firstpost
The study noted that the Pfizer–BioNTech shot worked against 15 additional possible mutations in the SARS-CoV-2 virus. A nurse holds a phial of the Pfizer-BioNTech COVID-19 vaccine at Guy’s Hospital…
-
Hyderabad: Sars-Cov-2 virus samples have been found in the hospital air of Covid-19 wards but not in non-Covid 19 wards, according to a CSIR-Centre for Cellular and Molecular Biology study.…
-
India has successfully cultured the new coronavirus strain, which originated in the UK, the Indian Council of Medical Research (ICMR) said on Saturday. In a tweet, the ICMR claimed that…
- General
New coronavirus strain in UK: SARS-CoV-2 variant appears more contagious, but is unlikely to render vaccines ineffective – Health News , Firstpost
The new variant came to the attention of researchers in December, when it began to turn up frequently in samples from parts of southern England In recent days, the…
- News
CSIR to decide on human clinical trials of Molnupiravir –– a drug that blocks SARS-CoV-2 in 24 hours
Written by Anuradha Mascarenhas | Pune | Updated: December 7, 2020 12:06:50 pm According to the researchers, Molnupiravir is the first oral anti-viral drug to quickly block SARS-CoV 2. (Representational…